CENTOGENE
CENTOGENE is one of the largest genetic biotech companies worldwide, the European market leader, and one of the global leaders in genetic diagnostic analyses of rare inherited diseases. Transforming global genetic data into medical decisions, that are focused on creating broarder awareness for patients of all ethnicities around the world. CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients. With headquarters in... Rostock, Germany and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families. CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.
CENTOGENE
Industry:
Biotechnology Clinical Trials Genetics Health Care Health Diagnostics
Founded:
2006-01-01
Address:
Rostock, Mecklenburg-Vorpommern, Germany
Country:
Germany
Website Url:
http://www.centogene.com
Total Employee:
251+
Status:
Active
Contact:
49 (0) 381- 80113 400
Email Addresses:
[email protected]
Total Funding:
89.93 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Mobile Non Scaleable Content Nginx Organization Schema
Similar Organizations
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
CareDx
CareDx is a novel molecular diagnostics company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
TVM Capital Life Science
TVM Capital Life Science investment in Post-IPO Equity - Centogene
Careventures
Careventures investment in Post-IPO Equity - Centogene
DPE Deutsche Private Equity
DPE Deutsche Private Equity investment in Post-IPO Equity - Centogene
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Centogene
CIC Capital
CIC Capital investment in Series A - Centogene
DPE Deutsche Private Equity
DPE Deutsche Private Equity investment in Series A - Centogene
TVM Capital Life Science
TVM Capital Life Science investment in Series A - Centogene
Careventures
Careventures investment in Series A - Centogene
Key Employee Changes
Official Site Inspections
http://www.centogene.com Semrush global rank: 705.66 K Semrush visits lastest month: 59.03 K
- Host name: ec2-3-65-75-157.eu-central-1.compute.amazonaws.com
- IP address: 3.65.75.157
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Centogene"
About Us: The CENTOGENE Story: centogene.com
CENTOGENE’s diagnostic footprint reaches far beyond our German roots. Having diagnosed over 2,500 rare diseases across 100 countries alongside a network of over 30,000 physicians, we have been spearheading revolutionary …See details»
Centogene - Crunchbase Company Profile & Funding
Centogene is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients. With headquarters in Rostock, Germany and further …See details»
Meet CENTOGENE's Leadership Team: centogene.com
Kim serves as CENTOGENE’s Chief Executive Officer. She has more than 30 years’ global commercial expertise in the biopharmaceutical space, with significant experience across multiple geographies, including Europe, the …See details»
Investor Relations - Centogene N.V.
Sep 25, 2024 CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for patients. With headquarters in …See details»
Centogene Company Profile 2024: Stock Performance …
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: …See details»
Centogene - Products, Competitors, Financials, Employees, …
Centogene is a company focused on providing data-driven solutions in the healthcare sector, specifically for rare and neurodegenerative diseases. The company offers diagnostic testing …See details»
Centogene - Leadership Team - The Org
The Leadership Team at Centogene is responsible for guiding the strategic direction of the company, ensuring alignment between clinical, commercial, and operational functions. …See details»
CENTOGENE Company Profile: Funding, Investors & Partnerships
CENTOGENE has been offering rapid and reliable diagnosis – building a network of approximately 30,000 active physicians. Our ISO, CAP, and CLIA certified multiomic reference …See details»
Centogene Company Profile - Office Locations, Competitors ... - Craft
Centogene has 4 employees across 8 locations and €48.54 m in annual revenue in FY 2023. See insights on Centogene including office locations, competitors, revenue, financials, executives, …See details»
CENTOGENE Signs Strategic Transaction With Private Equity …
Nov 13, 2024 Centogene N.V. (OTC: CNTGF) (“CENTOGENE” or the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today …See details»
CENTOGENE Biodata Network – Data-Driven Partnering Solutions: …
Leverage CENTOGENE's Biodata Network to accelerate drug discovery, clinical development, and commercialization in rare and neurodegenerative diseases. Learn more!See details»
A Brief History of Centogene – CBM
Oct 28, 2024 A Brief History of Centogene Founded in 2006, Centogene has rapidly emerged as a global leader in the field of genetic diagnostics and precision medicine. With a commitment …See details»
CENTOGENE Announces Changes in Senior Management Team
May 15, 2020 Amitay will continue his work for rare diseases patients in the non-profit sector, where he will serve as Chief Executive Officer of a patient advocacy organization. Prof. Arndt …See details»
News: Get the latest information, publications and news
Oct 10, 2023 CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading …See details»
CENTOGENE 's Laboratory Work is Internationally Accredited: …
CENTOGENE follows the strictest quality criteria to meet our customer’s requirements in clinical diagnostics, clinical trial services, and research and development. This is supported by …See details»
How to Order and Ship - CENTOGENE
At CENTOGENE, we understand the importance of timely and reliable transportation of biological samples to enable a diagnosis and accelerate treatment options. To help ease the stress of …See details»
CENTOGENE Trusted Leader in Genetic Testing services: …
CENTOGENE’s Clinical Dx footprint reaches far beyond our German roots. Having diagnosed over 2,500 rare diseases across 100 countries alongside a network of over 29,000 physicians, …See details»
Contact Us – We Are Here to Support You: centogene.com
You will receive an email with a confirmation link. Once you have clicked on that link, we will send you regular updates on what’s happening at CENTOGENE, including, but not limited to, …See details»
Our Tests: Reveal the Cause of Genetic Diseases: centogene.com
Our solutions are powered by the CENTOGENE Biodatabank, global clinical network, and deep medical expertise, as well as our proprietary CentoCard ®-based sample logistics system. We …See details»